Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine

Vaccine

Volumn 28, Issue 30, 2010, Pages 4802-4809

  Okamba, Faust René ^a,b   Arella, Maximilien ^a   Music, Nedzad ^b   Jia, Jian Jun ^b   Gottschalk, Marcelo ^b   Gagnon, Carl A ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Mycoplasma hyopneumoniae; P97 adhesin; Porcine enzootic pneumonia; Replication defective adenovirus; Vaccination

Indexed keywords

ADENOVIRUS VECTOR; ADHESIN; BACTERIAL VACCINE; BACTERIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; P97 ADHESIN; SUBUNIT VACCINE; SUVAXYN; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN G; P97 PROTEIN, MYCOPLASMA; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL GROWTH; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL PIG; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMAL PNEUMONIA OF SWINE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; TREATMENT RESPONSE; WEIGHT GAIN; ADENOVIRIDAE; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG; LUNG LAVAGE; MICROBIOLOGY; PATHOLOGY; PNEUMONIA OF SWINE, MYCOPLASMAL; SALIVA; SWINE; SWINE DISEASES;

ADENOVIRIDAE; ADHESINS, BACTERIAL; ANIMALS; ANTIBODY SPECIFICITY; BACTERIAL VACCINES; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LEUKOCYTE COUNT; LUNG; MYCOPLASMA HYOPNEUMONIAE; PNEUMONIA OF SWINE, MYCOPLASMAL; SALIVA; SWINE; SWINE DISEASES; VACCINES, SYNTHETIC; WEIGHT GAIN;

EID: 77954216570     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.089     Document Type: Article

References (43)

1. Thacker E.L. Mycoplasmal diseases. Diseases of swine 2006, 700-713. Iowa State University Press, Ames. 9th ed. B.E. Straw, J. Zimmermann, S. D'Allaire, D.J. Taylor (Eds.).
2. DeBey M.C., Ross R.F. Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures. Infect Immun 1994, 62(December (12)):5312-5318.
3. Zielinski G.C., Ross R.F. Adherence of Mycoplasma hyopneumoniae to porcine ciliated respiratory tract cells. Am J Vet Res 1993, 54(August (8)):1262-1269.
4. Thacker E.L., Halbur P.G., Ross R.F., Thanawongnuwech R., Thacker B.J. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J Clin Microbiol 1999, 37(March (3)):620-627.
5. Marois C., Dory D., Fablet C., Madec F., Kobisch M. Development of a quantitative Real-Time TaqMan PCR assay for determination of the minimal dose of Mycoplasma hyopneumoniae strain 116 required to induce pneumonia in SPF pigs. J Appl Microbiol 2010, 108(May (5)):1523-1533.
6. Okada M., Asai T., Ono M., Sakano T., Sato S. Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate. Vaccine 2000, 18(June (25)):2825-2831.
7. Lorenzo H., Quesada O., Assuncao P., Castro A., Rodriguez F. Cytokine expression in porcine lungs experimentally infected with Mycoplasma hyopneumoniae. Vet Immunol Immunopathol 2006, 109(February (3-4)):199-207.
8. Haesebrouck F., Pasmans F., Chiers K., Maes D., Ducatelle R., Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect?. Vet Microbiol 2004, 100(June (3-4)):255-268.
9. Maes D., Segales J., Meyns T., Sibila M., Pieters M., Haesebrouck F. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol 2008, 126(January (4)):297-309.
10. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6(February (2)):148-158.
11. Kim M.F., Heidari M.B., Stull S.J., McIntosh M.A., Wise K.S. Identification and mapping of an immunogenic region of Mycoplasma hyopneumoniae p65 surface lipoprotein expressed in Escherichia coli from a cloned genomic fragment. Infect Immun 1990, 58(August (8)):2637-2643.
12. Meens J., Selke M., Gerlach G.F. Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651. Vet Microbiol 2006, 116(August (1-3)):85-95.
13. Strasser M., Frey J., Bestetti G., Kobisch M., Nicolet J. Cloning and expression of a species-specific early immunogenic 36-kilodalton protein of Mycoplasma hyopneumoniae in Escherichia coli. Infect Immun 1991, 59(April (4)):1217-1222.
14. Fagan P.K., Djordjevic S.P., Eamens G.J., Chin J., Walker M.J. Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia. Infect Immun 1996, 64(March (3)):1060-1064.
15. Zhang Q., Young T.F., Ross R.F. Identification and characterization of a Mycoplasma hyopneumoniae adhesin. Infect Immun 1995, 63(March (3)):1013-1019.
16. Fagan P.K., Walker M.J., Chin J., Eamens G.J., Djordjevic S.P. Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs. Microb Pathog 2001, 30(February (2)):101-110.
17. Shimoji Y., Oishi E., Muneta Y., Nosaka H., Mori Y. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine 2003, 21(January (5-6)):532-537.
18. Ogawa Y., Oishi E., Muneta Y., Sano A., Hikono H., Shibahara T., et al. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector. Vaccine 2009, 27(July (33)):4543-4550.
19. Wilton J.L., Scarman A.L., Walker M.J., Djordjevic S.P. Reiterated repeat region variability in the ciliary adhesin gene of Mycoplasma hyopneumoniae. Microbiology 1998, 144(July (Pt 7)):1931-1943.
20. Meyns T., Maes D., Calus D., Ribbens S., Dewulf J., Chiers K., et al. Interactions of highly and low virulent Mycoplasma hyopneumoniae isolates with the respiratory tract of pigs. Vet Microbiol 2007, 120(February (1-2)):87-95.
21. Hsu T., Minion F.C. Identification of the cilium binding epitope of the Mycoplasma hyopneumoniae P97 adhesin. Infect Immun 1998, 66(October (10)):4762-4766.
22. Minion F.C., Adams C., Hsu T. R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia. Infect Immun 2000, 68(May (5)):3056-3060.
23. Jenkins C., Wilton J.L., Minion F.C., Falconer L., Walker M.J., Djordjevic S.P. Two domains within the Mycoplasma hyopneumoniae cilium adhesin bind heparin. Infect Immun 2006, 74(January (1)):481-487.
24. Papp Z., Babiuk L.A., Baca-Estrada M.E. Induction of immunity in the respiratory tract and protection from bovine herpesvirus type 1 infection by different routes of immunization with recombinant adenovirus. Viral Immunol 1998, 11(2):79-91.
25. Torres J.M., Sanchez C., Sune C., Smerdou C., Prevec L., Graham F., et al. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 1995, 213(November (2)):503-516.
26. Rosenthal K.L., Copeland K.F.T., Gallichan W.S. Recombinant adenoviruses as vectors for mucosal immunity 1996, 147-158. Mucosal Vaccines, San Diego. A. Press (Ed.).
27. Graham F.L. Growth of 293 cells in suspension culture. J Gen Virol 1987, 68(March (Pt 3)):937-940.
28. Fallaux F.J., Bout A., van der Velde I., van den Wollenberg D.J., Hehir K.M., Keegan J., et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998, 9(September (13)):1909-1917.
29. Okamba F.R., Moreau E., Cheikh Saad Bouh K., Gagnon C.A., Massie B., Arella M. Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin. Clin Vaccine Immunol 2007, 14(June (6)):767-774.
30. Sorensen V., Jorsal S.V., Mousing J. Diseases of the respiratory system. Diseases of swine 2006, 149-177. Iowa State University Press, Ames. 9th ed. B.E. Straw, J. Zimmermann, S. D'Allaire, D.J. Taylor (Eds.).
31. Mattoo S., Miller J.F., Cotter P.A. Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect Immun 2000, 68(April (4)):2024-2033.
32. Guo L., Wang J., Zhou H., Si H., Wang M., Song J., et al. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice. Vaccine 2008, 26(January (4)):460-468.
33. Lemiale F., Kong W.P., Akyurek L.M., Ling X., Huang Y., Chakrabarti B.K., et al. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 2003, 77(September (18)):10078-10087.
34. Xiang Z., Li Y., Gao G., Wilson J.M., Ertl H.C. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice. J Immunol 2003, 171(October (8)):4287-4293.
35. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Botran R., Coffman R.L., Mosmann T.R., et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988, 334(July (6179)):255-258.
36. King K.W., Faulds D.H., Rosey E.L., Yancey R.J. Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential. Vaccine 1997, 15(January (1)):25-35.
37. Thacker E.L., Thacker B.J., Boettcher T.B., Jayappa H. Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins. Swine Health Prod 1998, 6:107-112.
38. Sheldrake R.F., Romalis L.F., Saunders M.M. Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M hyopneumoniae. Res Vet Sci 1993, 55(November (3)):371-376.
39. Sarradell J., Andrada M., Ramirez A.S., Fernandez A., Gomez-Villamandos J.C., Jover A., et al. A morphologic and immunohistochemical study of the bronchus-associated lymphoid tissue of pigs naturally infected with Mycoplasma hyopneumoniae. Vet Pathol 2003, 40(July (4)):395-404.
40. Kishima M., Ross R.F. Suppressive effect of nonviable Mycoplasma hyopneumoniae on phytohemagglutinin-induced transformation of swine lymphocytes. Am J Vet Res 1985, 46(November (11)):2366-2368.
41. Vanden Bush T.J., Rosenbusch R.F. Characterization of the immune response to Mycoplasma bovis lung infection. Vet Immunol Immunopathol 2003, 94(July (1-2)):23-33.
42. Hechtman D.H., Cybulsky M.I., Fuchs H.J., Baker J.B., Gimbrone M.A., Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991, 147(August (3)):883-892.
43. Thanawongnuwech R., Thacker B., Halbur P., Thacker E.L. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae. Clin Diagn Lab Immunol 2004, 11(September (5)):901-908.